Clinical Trial Results:
A randomized, double-blind, double-dummy, two-way cross-over
study evaluating systemic bioavailability and airway clearance of
Symbicort® Turbuhaler® 320/9μg/inhalation versus Seretide™ Diskus
™50/500μg/inhalation after single inhalations in patients with Chronic
Obstructive Pulmonary Disease (COPD) and healthy volunteers
Summary
|
|
EudraCT number |
2006-002412-10 |
Trial protocol |
DE |
Global completion date |
22 Jul 2007
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
05 Jun 2016
|
First version publication date |
05 Jun 2016
|
Other versions |
|
Summary report(s) |
D5892C00012_synopsis.pdf |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.